4/30 CMA Webinar: Tax Impact of the CARES Act: COVID-19 Emergency Join CMA for a free webinar to learn about the latest federal incentives available to medical groups and physicians in light of the COVID-19 pandemic. April 1, 2020 CMA, Practice Management CARES Act, CMA, Coronavirus, COVID-19, Webinar 0 0 Comment Read More »
New DEA Buprenorphine Guidance The DEA issued guidance to DEA-registered physicians providing new flexibility for physicians managing patients with opioid use disorder. April 1, 2020 AMA AMA, Buprenorphine, Coronavirus, COVID-19, DEA, Opioids 0 0 Comment Read More »
Guidance Relating to Non-Discrimination in Medical Treatment for Novel Coronavirus 2019 (COVID-19) This joint bulletin reminds health care providers and payers that rationing care based on a person’s disability status is impermissible and unlawful under both federal and state law. April 1, 2020 Medical Board of CA, Public Health Coronavirus, CDPH, COVID-19, DHCS, Disabilities, DMHC 0 0 Comment Read More »